相关实验视频
Updated: Jan 10, 2026

07:43
Assaying Proteasomal Degradation in a Cell-free System in Plants
Published on: March 26, 2014
15.0K
蛋白质组:T细胞功能调节中的作用
Dongyang Tang1,2, Xiaoran Wu1,2, Josh Haipeng Lei1,2
1Cancer Center, Faculty of Health Sciences, University of Macau, Macau SAR, China.
International journal of biological sciences
|November 24, 2025
概括
蛋白质酶抑制剂在液体癌症中是有效的,但不是固体瘤. 了解它们在T细胞免疫中的作用可能会解锁新的癌症免疫疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 蛋白质酶对蛋白质稳态和细胞功能至关重要.
- 目前的蛋白酶体抑制剂在液体癌症中显示出有效性,但在固体瘤中成功程度有限.
- 新出现的证据强调了蛋白质酶在蛋白质降解之外的T细胞功能中的作用.
研究的目的:
- 审查蛋白质酶活性在T细胞生物学中的多方面的作用.
- 探索蛋白质酶抑制剂对T细胞介导的抗瘤免疫的影响.
- 通过使用蛋白酶体抑制剂来确定固体癌症和自身免疫性疾病的新型治疗策略.
主要方法:
- 文献综述总结了关于T细胞中蛋白质酶功能的当前知识.
- 探索蛋白质酶对T细胞选择,衰老,激活,分化和免疫逃避的影响.
- 讨论新兴技术,如CRISPR编辑,单细胞蛋白质组学和人工智能驱动的药物设计.
主要成果:
- 蛋白质组显著影响T细胞命运,包括抗原处理,代谢重编程和预防疲劳.
- 蛋白质酶抑制剂可以调节T细胞介导的抗瘤免疫力,这可能解释了它们在各种癌症中的差异性疗效.
- 了解这些机制为克服固体瘤抵抗提供了洞察力.
结论:
- 蛋白酶体在T细胞免疫中的作用对于其在癌症中的治疗潜力至关重要.
- 向蛋白酶体为开发用于固体瘤的新型免疫疗法提供了有希望的途径.
- 先进的技术可能会扩大蛋白酶体抑制剂在治疗癌症和自身免疫性疾病中的应用.
相关概念视频
The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
The Proteasome
4.4K
4.4K
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Regulated Protein Degradation
3.1K
3.1K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K

